Malignant Hyperthermia: Difference between revisions

Malignant Hyperthermia (view source)

177 bytes added , 2 years ago

no edit summary

3,688

edits

Revision as of 11:19, 25 June 2022 (view source) WikiSysop (talk \| contribs) No edit summary ← Older edit		Revision as of 18:15, 14 October 2022 (view source) WikiSysop (talk \| contribs) No edit summary Newer edit →
Line 28:		Line 28:

	Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing. Anesthesiology. 2022 Jun 1;136(6):940-953. PMID: 35285867		Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing. Anesthesiology. 2022 Jun 1;136(6):940-953. PMID: 35285867

			[https://www.bjanaesthesia.org/article/S0007-0912(22)00496-2/fulltext Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia]